Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/28101
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2018-03-20T11:47:36Z-
dc.date.available2018-03-20T11:47:36Z-
dc.date.issued2017-
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/28101-
dc.descriptionB.SC.(HONS)BIOMED.SCI.en_GB
dc.description.abstractFibrinogen is a haemostatic protein which causes blood to clot. It is mainly produced in the liver thus liver diseases such as cirrhosis may affect the levels of fibrinogen leading to bleeding diatheses. There are both quantitative and qualitative tests that can be used to measure the level of fibrinogen. However, there is no agreement yet on which test is preferred for estimating fibrinogen levels in liver disease. This project aims at comparing four different methodologies (Clauss Fibrinogen, PT-derived Fibrinogen (PT-Fg), Fibrinogen Antigen and Functional Fibrinogen Thromboelastography (FF-TEG)) for estimating fibrinogen levels in patients with liver disease, to determine differences in fibrinogen levels between the assays and severity of liver disease. This project tries to determine which assay might give the best reflection of fibrinogen levels in this cohort of patients. A total of 55 liver cirrhotic patients (26 Child-Pugh A, 14 Child-Pugh B and 15 Child-Pugh C) and 20 healthy control individuals were recruited. All 4 assays correlate strongly with each other but give significantly different mean fibrinogen levels, in both patients and healthy controls. PT-Fg gave the highest mean fibrinogen levels as opposed to the Clauss, which gave the lowest. A non-significant trend was observed in all assays showing higher levels in Child-Pugh A, normal in Child-Pugh B and decreased in Child- Pugh C when compared to normal. A significant difference was only observed between Child-Pugh A and Child-Pugh C in the Clauss, PT-Fg and Fibrinogen Antigen but not Functional Fibrinogen Level (FLEV). There were no apparent differences according to Child-Pugh and healthy controls in FLEV, pointing to a normal fibrin clot strength in liver cirrhosis. Since neither of the assays could differentiate between a healthy control and any cirrhotic, this signifies that plasma fibrinogen levels alone, cannot be used to indicate the severity of the liver cirrhosis. Through linear regression models, the fitted Clauss Fibrinogen levels were established from the cheaper PT-Fg assay.en_GB
dc.language.isoenen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectFibrinogenen_GB
dc.subjectLiver -- Diseasesen_GB
dc.subjectLiver -- Cirrhosisen_GB
dc.titleFibrinogen estimation in patients with liver diseaseen_GB
dc.typebachelorThesisen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Health Sciences. Department of Applied Biomedical Scienceen_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorRizzo, Kirsty-
Appears in Collections:Dissertations - FacHSc - 2017
Dissertations - FacHScABS - 2017

Files in This Item:
File Description SizeFormat 
17BSABS12.pdf
  Restricted Access
7.83 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.